Unicon Investment has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 465, in its February 24, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!